Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

A Housing Fix or a Political Play? Trump Targets Institutional Buyers

Jeff Ostrowski, Housing Market Analyst at Bankrate, analyzes whether banning corporate buyers would help affordability or worsen supply shortages.

Big Business This Week: Will pressure on Fed chair Powell backfire?

The last 12 months have seen an extraordinary change in the way the U.S. economy works. Some analysts say that hasn’t been working out very well.

Oil Under U.S. Control? Breaking Down the Maduro Capture and Market Impacts

The U.S. is asserting control over Venezuelan oil after capturing President Maduro. Energy reporter Ben Geman of Axios breaks down what it means for markets and

From Stigma to Strategy: The Next Chapter for U.S. Cannabis Investing

Renewed investor interest and possible federal reforms may mark a turning point for U.S. cannabis. AdvisorShares’ Dan Ahrens explains what’s next.

Is Silver the Next Gold? Expert Predicts Historic Rally Ahead

Silver is back in the spotlight as supply constraints, surging industrial demand, and macro trends push prices high, possibly heading toward $100/ounce.

Is the U.S. Job Market Losing Steam? Inside the “Stall Speed” Economy

With paid job posts down 13%, LinkedIn’s Kory Kantenga explains what the latest labor data signals for workers and employers.

Load More